191 related articles for article (PubMed ID: 9607618)
1. p53 protein overexpression and response to induction chemoradiation therapy in patients with locally advanced rectal adenocarcinoma.
Luna-Perez P; Arriola EL; Cuadra Y; Alvarado I; Quintero A
Ann Surg Oncol; 1998; 5(3):203-8. PubMed ID: 9607618
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of retrieved lymph nodes per specimen in resected rectal adenocarcinoma after preoperative chemoradiation therapy.
Luna-Pérez P; Rodríguez-Ramírez S; Alvarado I; Gutiérrez de la Barrera M; Labastida S
Arch Med Res; 2003; 34(4):281-6. PubMed ID: 12957524
[TBL] [Abstract][Full Text] [Related]
3. p53 immunohistochemical staining predicts residual disease after chemoradiation in patients with high-risk rectal cancer.
Spitz FR; Giacco GG; Hess K; Larry L; Rich TA; Janjan N; Cleary KR; Skibber JM
Clin Cancer Res; 1997 Oct; 3(10):1685-90. PubMed ID: 9815551
[TBL] [Abstract][Full Text] [Related]
4. Radiotherapy, concomitant protracted-venous-infusion 5-fluorouracil, and surgery for ultrasound-staged T3 or T4 rectal cancer.
Mehta VK; Poen J; Ford J; Edelstein PS; Vierra M; Bastidas AJ; Young H; Fisher G
Dis Colon Rectum; 2001 Jan; 44(1):52-8. PubMed ID: 11805563
[TBL] [Abstract][Full Text] [Related]
5. Thymidylate synthase, thymidine phosphorylase, dihydropyrimidine dehydrogenase expression, and histological tumour regression after 5-FU-based neo-adjuvant chemoradiotherapy in rectal cancer.
Jakob C; Aust DE; Meyer W; Baretton GB; Schwabe W; Häusler P; Becker H; Liersch T
J Pathol; 2004 Dec; 204(5):562-8. PubMed ID: 15538739
[TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of response to preoperative infusional chemoradiation in locally advanced rectal cancer.
Janjan NA; Abbruzzese J; Pazdur R; Khoo VS; Cleary K; Dubrow R; Ajani J; Rich TA; Goswitz MS; Evetts PA; Allen PK; Lynch PM; Skibber JM
Radiother Oncol; 1999 May; 51(2):153-60. PubMed ID: 10435807
[TBL] [Abstract][Full Text] [Related]
7. Can p53 alterations be used to predict tumour response to pre-operative chemo-radiotherapy in locally advanced rectal cancer?
Elsaleh H; Robbins P; Joseph D; Powell B; Grieu F; Menso L; Iacopetta B
Radiother Oncol; 2000 Aug; 56(2):239-44. PubMed ID: 10927144
[TBL] [Abstract][Full Text] [Related]
8. Tumor response to neoadjuvant chemoradiation therapy for rectal adenocarcinoma is mediated by p53-dependent and caspase 8-dependent apoptotic pathways.
Kelley ST; Coppola D; Yeatman T; Marcet J
Clin Colorectal Cancer; 2005 Jul; 5(2):114-8. PubMed ID: 16098252
[TBL] [Abstract][Full Text] [Related]
9. p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.
Saw RP; Morgan M; Koorey D; Painter D; Findlay M; Stevens G; Clarke S; Chapuis P; Solomon MJ
Dis Colon Rectum; 2003 Feb; 46(2):192-202. PubMed ID: 12576893
[TBL] [Abstract][Full Text] [Related]
10. Expression of epidermal growth factor receptor as a predictive factor for rectal cancer.
Motlagh A; Azadeh P; Fazlalizadeh A; Shahrad B; Shafaghi B; Fudazi M; Yosefi A; Davaei M
Arch Iran Med; 2007 Jul; 10(3):301-8. PubMed ID: 17604465
[TBL] [Abstract][Full Text] [Related]
11. Survivin, p53, and Ki-67 as predictors of histopathologic response in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
Terzi C; Canda AE; Sagol O; Atila K; Sonmez D; Fuzun M; Gorken IB; Oztop I; Obuz F
Int J Colorectal Dis; 2008 Jan; 23(1):37-45. PubMed ID: 17805549
[TBL] [Abstract][Full Text] [Related]
12. Preoperative radio-chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.
Cambray i Amenós M; Navarro García M; Martí Ragué J; Pareja Fernández L; Pera Fábregas J
Clin Transl Oncol; 2007 Mar; 9(3):183-91. PubMed ID: 17403630
[TBL] [Abstract][Full Text] [Related]
13. Does downstaging predict improved outcome after preoperative chemoradiation for extraperitoneal locally advanced rectal cancer? A long-term analysis of 165 patients.
Valentini V; Coco C; Picciocchi A; Morganti AG; Trodella L; Ciabattoni A; Cellini F; Barbaro B; Cogliandolo S; Nuzzo G; Doglietto GB; Ambesi-Impiombato F; Cosimelli M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):664-74. PubMed ID: 12062610
[TBL] [Abstract][Full Text] [Related]
14. Long-term results using local excision after preoperative chemoradiation among selected T3 rectal cancer patients.
Bonnen M; Crane C; Vauthey JN; Skibber J; Delclos ME; Rodriguez-Bigas M; Hoff PM; Lin E; Eng C; Wong A; Janjan NA; Feig BW
Int J Radiat Oncol Biol Phys; 2004 Nov; 60(4):1098-105. PubMed ID: 15519780
[TBL] [Abstract][Full Text] [Related]
15. Preoperative chemoradiation for rectal cancer causes prolonged pudendal nerve terminal motor latency.
Lim JF; Tjandra JJ; Hiscock R; Chao MW; Gibbs P
Dis Colon Rectum; 2006 Jan; 49(1):12-9. PubMed ID: 16292664
[TBL] [Abstract][Full Text] [Related]
16. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
[TBL] [Abstract][Full Text] [Related]
17. The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer.
Crane CH; Skibber JM; Birnbaum EH; Feig BW; Singh AK; Delclos ME; Lin EH; Fleshman JW; Thames HD; Kodner IJ; Lockett MA; Picus J; Phan T; Chandra A; Janjan NA; Read TE; Myerson RJ
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):84-9. PubMed ID: 12909219
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for anastomotic leakage after preoperative chemoradiation therapy and low anterior resection with total mesorectal excision for locally advanced rectal cancer.
Rodríguez-Ramírez SE; Uribe A; Ruiz-García EB; Labastida S; Luna-Pérez P
Rev Invest Clin; 2006; 58(3):204-10. PubMed ID: 16958295
[TBL] [Abstract][Full Text] [Related]
20. Preoperative capecitabine and accelerated intensity-modulated radiotherapy in locally advanced rectal cancer: a phase II trial.
Ballonoff A; Kavanagh B; McCarter M; Kane M; Pearlman N; Nash R; Shah RJ; Raben D; Schefter TE
Am J Clin Oncol; 2008 Jun; 31(3):264-70. PubMed ID: 18525306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
